S&P 500   3,828.68 (+0.23%)
DOW   31,324.44 (+0.17%)
QQQ   310.50 (+0.43%)
AAPL   122.65 (+0.48%)
MSFT   230.81 (+1.43%)
FB   262.26 (+2.68%)
GOOGL   2,047.90 (+1.81%)
TSLA   648.24 (-0.76%)
AMZN   3,047.99 (+1.43%)
NVDA   508.45 (-0.73%)
BABA   234.02 (-0.95%)
CGC   31.80 (-4.33%)
GE   13.54 (+0.74%)
MU   86.67 (-2.74%)
NIO   40.79 (-1.78%)
AMD   80.35 (-0.63%)
T   28.99 (+0.94%)
F   12.15 (-0.16%)
ACB   10.10 (-3.44%)
DIS   189.32 (-1.53%)
BA   229.48 (+0.40%)
NFLX   527.30 (+1.27%)
PFE   34.87 (+1.40%)
S&P 500   3,828.68 (+0.23%)
DOW   31,324.44 (+0.17%)
QQQ   310.50 (+0.43%)
AAPL   122.65 (+0.48%)
MSFT   230.81 (+1.43%)
FB   262.26 (+2.68%)
GOOGL   2,047.90 (+1.81%)
TSLA   648.24 (-0.76%)
AMZN   3,047.99 (+1.43%)
NVDA   508.45 (-0.73%)
BABA   234.02 (-0.95%)
CGC   31.80 (-4.33%)
GE   13.54 (+0.74%)
MU   86.67 (-2.74%)
NIO   40.79 (-1.78%)
AMD   80.35 (-0.63%)
T   28.99 (+0.94%)
F   12.15 (-0.16%)
ACB   10.10 (-3.44%)
DIS   189.32 (-1.53%)
BA   229.48 (+0.40%)
NFLX   527.30 (+1.27%)
PFE   34.87 (+1.40%)
S&P 500   3,828.68 (+0.23%)
DOW   31,324.44 (+0.17%)
QQQ   310.50 (+0.43%)
AAPL   122.65 (+0.48%)
MSFT   230.81 (+1.43%)
FB   262.26 (+2.68%)
GOOGL   2,047.90 (+1.81%)
TSLA   648.24 (-0.76%)
AMZN   3,047.99 (+1.43%)
NVDA   508.45 (-0.73%)
BABA   234.02 (-0.95%)
CGC   31.80 (-4.33%)
GE   13.54 (+0.74%)
MU   86.67 (-2.74%)
NIO   40.79 (-1.78%)
AMD   80.35 (-0.63%)
T   28.99 (+0.94%)
F   12.15 (-0.16%)
ACB   10.10 (-3.44%)
DIS   189.32 (-1.53%)
BA   229.48 (+0.40%)
NFLX   527.30 (+1.27%)
PFE   34.87 (+1.40%)
S&P 500   3,828.68 (+0.23%)
DOW   31,324.44 (+0.17%)
QQQ   310.50 (+0.43%)
AAPL   122.65 (+0.48%)
MSFT   230.81 (+1.43%)
FB   262.26 (+2.68%)
GOOGL   2,047.90 (+1.81%)
TSLA   648.24 (-0.76%)
AMZN   3,047.99 (+1.43%)
NVDA   508.45 (-0.73%)
BABA   234.02 (-0.95%)
CGC   31.80 (-4.33%)
GE   13.54 (+0.74%)
MU   86.67 (-2.74%)
NIO   40.79 (-1.78%)
AMD   80.35 (-0.63%)
T   28.99 (+0.94%)
F   12.15 (-0.16%)
ACB   10.10 (-3.44%)
DIS   189.32 (-1.53%)
BA   229.48 (+0.40%)
NFLX   527.30 (+1.27%)
PFE   34.87 (+1.40%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Moleculin BiotechCannTrustCV SciencesRegeneRx BiopharmaceuticalsCelsion
SymbolNASDAQ:MBRXOTCMKTS:CNTTFOTCMKTS:CVSIOTCMKTS:RGRXNASDAQ:CLSN
Price Information
Current Price$3.85N/A$0.66$0.65$1.78
52 Week RangeBuyN/AHoldN/AHold
MarketRank™
Overall Score1.20.91.10.61.3
Analysis Score3.50.02.10.03.0
Community Score2.72.62.62.82.7
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.01.90.60.00.6
Analyst Ratings
Consensus RecommendationBuyN/AHoldN/AHold
Consensus Price Target$15.00N/A$0.78N/A$4.00
% Upside from Price Target289.61% upsideN/A19.59% upsideN/A124.72% upside
Trade Information
Market Cap$105.90 million$67.40 million$69.81 million$86.74 million$76.33 million
Beta2.114.520.451.012.42
Average Volume3,359,002528,0251,682,776156,73226,956,904
Sales & Book Value
Annual RevenueN/A$15.96 million$53.70 million$80,000.00$500,000.00
Price / SalesN/A0.001.301,084.22133.21
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.34 per shareN/A$0.29 per share($0.02) per share$0.63 per share
Price / BookN/ANaN2.26-32.502.83
Profitability
Net Income$-13,200,000.00N/A$-16,610,000.00$-1,400,000.00$-16,850,000.00
EPS($0.32)$0.07($0.17)N/A($0.91)
Trailing P/E RatioN/A137.18N/A0.00N/A
Forward P/E RatioN/A0.00N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-68.90%-1,976.61%-4,315.00%
Return on Equity (ROE)-113.25%N/A-81.99%N/A-104.32%
Return on Assets (ROA)-63.20%N/A-42.70%-279.41%-47.65%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.13%N/A0.25%
Current Ratio4.44%N/A1.93%0.57%3.67%
Quick Ratio4.44%N/A1.24%0.57%3.67%
Ownership Information
Institutional Ownership Percentage4.82%0.08%0.01%0.17%13.73%
Insider Ownership Percentage8.30%N/A14.60%11.60%20.49%
Miscellaneous
Employees11N/A118329
Shares Outstanding26.28 million105.61 million106.58 million133.44 million37.42 million
Next Earnings Date3/18/2021 (Estimated)N/A3/15/2021 (Estimated)3/5/2021 (Estimated)3/24/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.